Putting Diabetes Patients on the Right Track to Monitor Blood Sugar Painlessly

By: DGI Wire

Diabetes

NEW YORK– (DGIwire) — Blood sugar tests are conventionally performed with a portable electronic device that analyzes a drop of blood and provides important information for diabetes patients.

Now imagine if these patients could eliminate the need to draw their own blood, thus avoiding the pain linked with daily blood sugar testing. If this were possible, they would almost certainly be more eager to monitor themselves every single day. It could also make a profound difference to their long-term health.

Of the huge number of people with diabetes—25.8 million people in the U.S. alone, according to the American Diabetes Association—90 percent have Type 2 diabetes. It is important to understand the consequences of failing to test their blood sugar; otherwise, “non-compliant” diabetes patients could subject themselves to a variety of unpleasant and even life-threatening complications.

Soon, however, diabetes patients might no longer need to prick themselves to draw blood daily. This positive development is due to a Israel-based company named Integrity Applications, led by co-founder, CEO and President Avner Gal, an electrical engineer and former commander in the Israeli Navy. He and his team have developed a painless blood glucose testing device called GlucoTrack®. Easy to use and noninvasive, the device is designed for everyone with diabetes, regardless of age or body type.

GlucoTrack harnesses a patented combination of ultrasonic, electromagnetic and thermal technologies that together provide accurate blood glucose measurements without drawing blood. A small sensor clips comfortably to the earlobe; this activates a proprietary algorithm and the wearer’s blood glucose level is calculated. The result is displayed on the small portable unit.

Researchers at Johns Hopkins University recently issued a report suggesting that people with Type 2 diabetes should ideally monitor their blood sugar levels more than once a day to monitor the risk of developing cardiovascular disease and stroke—a risk that is elevated when blood sugar levels exceed 150 milligrams per deciliter on a regular basis.

With GlucoTrack, compliance could be made substantially easier.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.